Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Lithotripsy Does Not Promote Diabetes or Hypertension

By HospiMedica International staff writers
Posted on 06 Jul 2011
Shock wave lithotripsy (SWL) for removing kidney stones does not increase a patients' risk of diabetes mellitus (DM) and hypertension, according to a new study. More...


Researchers at the University of British Columbia (Vancouver, Canada) conducted a retrospective review of 727 patients who underwent SWL at Vancouver General Hospital (Canada) between 1985 and 1989. The researchers compared the prevalence of hypertension and DM in patients treated with an unmodified HM-3 lithotripter (USWL) and a second-generation modified HM-3 lithotripter (MSWL) to determine whether the type of lithotripter was differentially associated with the development of these sequelae. The response rate was 37.3%.

The results showed a greater proportion than average of overweight and obese individuals in the study group; hypertension was more prevalent in all lithotripsy subjects. In univariate analysis, lithotripsy with an USWL was associated with a higher rate of DM than the provincial rate, whereas lithotripsy with the MSWL was not; on multivariate analysis, however, the type of lithotripter was not associated with the development of either outcome. The researchers therefore postulated that the development of renal calculi was more indicative of an overall metabolic syndrome not related to shockwave lithotripsy, but rather to a systemic metabolic dysfunction. The study was published in the June 2, 2011, issue of BJU International.

“What we can tell our patients is that shockwave lithotripsy to treat kidney stones is safe and that it does not cause diabetes or hypertension,” said lead author Ben Chew, MD, of the department of urologic sciences. “Patients with kidney stones should be monitored closely for the development of hypertension and diabetes. Overweight patients should be counseled to lose weight and exercise.”

Shockwave lithotripsy is a noninvasive treatment of kidney stones and biliary calculi using an acoustic pulse. The pulses are initially administered at a slow rate for more effective comminution of the stone and to minimize morbidity; power levels are then gradually increased, so as to break up the stone. The final power level usually depends on the patient's pain threshold and the observed success of stone breakage. The successive shock wave pressure pulses result in direct shearing forces, as well as cavitation bubbles surrounding the stone, which fragment the stones into smaller pieces that then can easily pass through the ureters or the cystic duct. The process takes about an hour.

Related Links:
University of British Columbia
Vancouver General Hospital


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.